Health

Results: 1225-1236 of 7444

Yorkshire Cancer Research Outside Parliament - June2025

White Rose Ride: Tanfield Brothers Back Campaign to Tackle Yorkshire Cancer Inequalities

ESC Congress 2025: OMRON Healthcare to Spotlight Risks of Undiagnosed Heart Failure in Women

Invitation to presentation of BioArctic's second quarter report for April - June 2025 on August 28 at 9.30 a.m. CET

PR Newswire associated0

Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site

PR Newswire associated0

Jazz Pharmaceuticals to Host Modeyso™ (dordaviprone) Investor Webcast on August 27, 2025

NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update

King Faisal Specialist Hospital Provides Nearly 300,000 Virtual Consultations in 2024

Zylox-Tonbridge Announces 2025 Interim Results: Strong Revenue Growth with Net Profit Surging Over 76% Year-over-Year

PR Newswire associated0

Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue and Profit Growth

PR Newswire associated0

Vital Materials Released Quantum Flux Photon Counting CT (PCCT) Full Vertical Integration Technology

Ping An Good Doctor (1833.HK) Reports Strong Interim Results: Revenue and Profit Accelerate as AI Fuels New Growth Momentum

Driven by athlete feedback, the new Hyperice X 2 unlocks a new era of contrast recovery tech with powerful multi-level compression. With advanced technology tested and proven by athletes, Hyperice X 2 Knee and Hyperice X 2 Shoulder bring elite-level warm-up and recovery contrast therapy solutions in a new, user-friendly device designed for everyday use.

Hyperice Unveils Next Generation of Contrast Therapy Innovation, Hyperice X 2 Knee and Hyperice X 2 Shoulder